Physician profile
Kenneth Rosen
NPI 1982625406
$3,981.05
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $503 · 2021: $758 · 2022: $776 · 2023: $633 · 2024: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.38 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,132.09 | 2020-2024 | Skyrizi |
| Janssen Biotech, INC. | $818.17 | 2019-2024 | Tremfya |
| Leo Pharma INC. | $372.70 | 2019-2024 | Adbry |
| Novartis Pharmaceuticals Corporation | $247.78 | 2019-2024 | |
| Lilly USA, LLC | $243.60 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $194.80 | 2019-2024 | Dupixent, Libtayo |
| Ucb, INC. | $154.79 | 2019-2023 | Bimzelx, Cimzia |
| Genzyme Corporation | $129.91 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $124.49 | 2023-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $87.61 | 2019-2022 | |
| Amgen INC. | $79.37 | 2019-2022 | |
| Incyte Corporation | $55.58 | 2023-2024 | Opzelura |
| Strata Skin Sciences, INC. | $53.47 | 2023-2024 | Xtrac |
| Pfizer INC. | $42.42 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $40.80 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.02 | 2019-2024 | Jublia, Arazlo |
| Nabriva Therapeutics, Plc | $36.22 | 2022 | |
| Verrica Pharmaceuticals INC. | $34.70 | 2023 | Ycanth |
| Vyne Pharmaceuticals INC. | $23.50 | 2021 | |
| Mayne Pharma Commercial LLC | $19.37 | 2023 | |
| Allergan, INC. | $18.23 | 2020 | |
| Almirall LLC | $17.90 | 2021 | |
| Arcutis Biotherapeutics, INC. | $14.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.